×

Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics

  • US 8,039,443 B2
  • Filed: 11/02/2004
  • Issued: 10/18/2011
  • Est. Priority Date: 11/21/2002
  • Status: Expired due to Fees
First Claim
Patent Images

1. A monotherapy regimen for reducing angiogenesis and neovascularization in a tumor comprising the step of administering a therapeutically effective amount of an aptamer having the following structure:

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×